Grace Dy
MD
Professor of Oncology
👥Biography 个人简介
Dr. Grace Dy is a thoracic oncologist who participated in the CodeBreaK 200 pivotal trial comparing sotorasib to docetaxel in pretreated KRAS G12C-mutant NSCLC, which led to sotorasib's full FDA approval. Her research encompasses predictive biomarkers for KRAS inhibitor response and the mechanisms underlying primary and acquired resistance. She is active in multisite collaborative trials for lung cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Grace Dy 的研究动态
Follow Grace Dy's research updates
留下邮箱，当我们发布与 Grace Dy（Roswell Park Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment